DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/15922
Title: Chitosan coated chlorogenic acid and rutincomposite phospholipid liposomes: Preparation, characterizations, permeability and pharmacokinetic
Authors: Zeng, Cheng
Zheng, Ruifang
Jiang, Wen
He, Chenghui
Li, Jianguang
Xing, Jianguo
Keywords: Chlorogenic acid
rutin
composite phospholipid liposome
chitosan
permeability
pharmacokinetic
Issue Date: 11-Sep-2018
Publisher: Karachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachi
Citation: Zeng, C., Zheng, R., Jiang, W., He, C., Li, J., & Xing, J. (2018). Chitosan coated chlorogenic acid and rutincomposite phospholipid liposomes: Preparation, characterizations, permeability and pharmacokinetic. Pakistan Journal of Pharmaceutical Sciences.
Abstract: In order to research and enhance bioavailability of chlorogenic acid and rutin(CA-R) via the oral route, chitosan coated composite phospholipid liposomes (C-CPLs) were applied to study on preparation, permeability and pharmacokinetic of C-CA-R-CPLs. TheC-CA-R-CPLs were prepared by the method of ethanol injection. The entrapment efficiency (EE), average particle sizes, polymer disperse index (PDI), zeta potential, shape and in vitro drug release were investigated to characterize physicochemical parameters of C-CA-R-CPLs. The penetration properties from C-CA-R-CPLs were studied through Caco-2 cells model and the pharmacokinetics in Sprague-Dawley (SD) rats were evaluated by rat jugular vein intubation tube. The EE of C-CA-R-CPLs of CA and R was 91.3±2.13% and 92.6±2.44%, particle size of C-CA-R-CPLs was 176.7±2.3 nm, PDI was 0.207±0.014 and zeta potential of 12.61±1.33 mV. CA-RCPLs and C-CA-R-CPLs were spherical or elliptical sphere and the bilayer of the CPL was observed obviously under transmission electron. The C max, t1/2 and AUC0-12 h values of CA and R for groups of C-CA-R-CPLs were significantly increased.In conclusion, TheC-CA-R-CPLs as a novel nano-formulation have potential to be used to enhance the oral bioavailability of poorlywater-soluble drugs after oral administration.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/15922
ISSN: 1011-601X
Appears in Collections:Issue No.5 (Supplementary)

Files in This Item:
File Description SizeFormat 
11-SUP-913.htm147 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.